子宫内膜癌林奇综合征检测策略的系统评价
该系统评价评估了免疫组化(IHC)和微卫星不稳定(MSI)检测(联合或不联合MLH1启动子甲基化检测)在子宫内膜癌患者中诊断林奇综合征的准确性。特异性普遍较低。未发现IHC与MSI策略间准确性有统计学显著差异。
要点
- IHC和MSI检测对林奇综合征的敏感性较高,但特异性普遍较低。
- 联合IHC、MSI和MLH1启动子甲基化检测的敏感性达90.5-100%。
- 头对头研究未显示IHC与MSI策略的准确性存在统计学显著差异。
核心结论
- IHC和MSI检测对子宫内膜癌患者林奇综合征的敏感性普遍较高,但特异性多较低。
- 无证据表明IHC与MSI策略的检测准确性存在差异。
- 现有证据基础较小且偏倚风险高。
研究设计与样本
- 由两名评价员独立完成各阶段筛选与提取。
主要发现
- IHC敏感性范围为60.7-100%,MSI敏感性范围为41.7-100%,联合策略敏感性范围为90.5-100%。
- IHC特异性范围为60.9-83.3%(排除1项高度选择性纳入标准的研究),MSI特异性范围为69.2-89.9%,联合策略特异性范围为72.4-92.3%(排除1项高度选择性纳入标准的研究)。
- 头对头比较IHC与MSI策略的研究中,敏感性和特异性均无统计学显著差异。
- 报告的检测失败罕见。
临床怎么用
- 临床可考虑使用IHC或MSI检测(联合或不联合MLH1启动子甲基化检测)筛查子宫内膜癌患者的林奇综合征。
- 解读检测结果时需注意特异性较低可能带来的假阳性风险。
局限性
- 纳入研究数量少且异质性大,无法进行数据合并。
- 无研究在所有偏倚风险领域均为低风险。
- 证据基础较小且偏倚风险高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lynch syndrome is an inherited genetic condition that is associated with an increased risk of cancer, including endometrial and colorectal cancer. We assessed the test accuracy of immunohistochemistry and microsatellite instability-based testing (with or without MLH1 promoter methylation testing) for Lynch syndrome in women with endometrial cancer. METHODS: We conducted a systematic review of literature published up to August 2019. We searched bibliographic databases, contacted experts and checked reference lists of relevant studies. Two reviewers conducted each stage of the review. RESULTS: Thirteen studies were identified that included approximately 3500 participants. None of the studies was at low risk of bias in all domains. Data could not be pooled due to the small number of heterogeneous studies. Sensitivity ranged from 60.7-100% for immunohistochemistry, 41.7-100% for microsatellite instability-based testing, and 90.5-100% for studies combining immunohistochemistry, microsatellite instability-based testing, and MLH1 promoter methylation testing. Specificity ranged from 60.9-83.3% (excluding 1 study with highly selective inclusion criteria) for immunohistochemistry, 69.2-89.9% for microsatellite instability-based testing, and 72.4-92.3% (excluding 1 study with highly selective inclusion criteria) for testing strategies that included immunohistochemistry, microsatellite instability-based testing, and MLH1 promoter methylation. We found no statistically significant differences in test accuracy estimates (sensitivity, specificity) in head-to-head studies of immunohistochemistry versus microsatellite instability-based testing. Reported test failures were rare. CONCLUSIONS: Sensitivity of the index tests were generally high, though most studies had much lower specificity. We found no evidence that test accuracy differed between IHC and MSI based strategies. The evidence base is currently small and at high risk of bias.
引用
- Stinton C, Fraser H, Al-Khudairy L, et al. Testing for lynch syndrome in people with endometrial cancer using immunohistochemistry and microsatellite instability-based testing strategies - A systematic review of test accuracy. Gynecol Oncol. 2020. PMID: 33190932. doi:10.1016/j.ygyno.2020.10.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。